Hancock Whitney agreed to sell $497 million of energy loans to certain funds and accounts managed by Oaktree Capital Management.
Acosta has successfully completed its financial reorganization and recapitalization and emerged from Chapter 11 less than a month after filing.
Sorrento Therapeutics, a clinical-stage immunotherapy biotech company, closed a debt financing for up to $150 million. The financing was provided by funds and accounts managed by Oaktree Capital Management.
Assembled Brands, the company financing emerging consumer goods brands, closed $100 million permanent capital from funds managed by Oaktree Capital Management.
An affiliate of Cerberus Capital Management completed its previously announced acquisition of Cyanco Holding from funds managed by Oaktree Capital Management.
An affiliate of Cerberus Capital Management will acquire Cyanco Holding from funds managed by Oaktree Capital Management.
Oxford BioMedica, a gene and cell therapy group, completed a new $55 million debt facility with Oaktree Capital Management.
SunOpta, a global company focused on organic, non-genetically modified and specialty foods, entered into an agreement with Oaktree Capital Management to secure $85 million in equity financing. Kirkland & Ellis advised Oaktree.
It’s spring! Oaktree Capital Management is branching out and launching Encina Business Credit, an independent asset-based lending platform. Artist Jerry Gonzalez illustrates this new financial planting.
Encina Capital Partners and an affiliate of Oaktree Capital Management launched Encina Business Credit, a new, independent asset-based lending platform targeting middle-market borrowers in the U.S. and Canada.